Verzenio 100 MG tablet UU 14S
Ended Awarded
- Contract number
- SPE2DB26FABD1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,239
Award facts
- Contract value 100% obligated
- $25,239.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Verzenio 100 mg tablets (14-count unit of use packaging) with a contract ceiling value of $25,239.45. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award. The contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical supply is scheduled for completion by November 4, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. military, and veteran healthcare systems. The SPE2DX IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products, medical supplies, and specialty medications globally to support military healthcare programs. This particular delivery order for Verzenio, a prescription oncology medication, is representative of AmerisourceBergen's extensive pharmaceutical portfolio under the DLA contract vehicle, which encompasses brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FABD1?
SPE2DB26FABD1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FABD1 worth?
The government has obligated $25,239 on SPE2DB26FABD1.
Is contract SPE2DB26FABD1 an order under another contract?
Yes. SPE2DB26FABD1 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB26FABD1 competed?
The extent of competition for SPE2DB26FABD1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award